2023 annual financial data
Edesa Biotech 2023 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -9,222,758 USD and net income was -8,374,415 USD.
Operating cash flow was -6,636,483 USD.
Get free Edesa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -9,222,758 USD
- Net income
- -8,374,415 USD
- Operating cash flow
- -6,636,483 USD